Abstract
Long-term ketamine abuse is known to affect the lower urinary tract and produce symptoms of cystitis. However, the pathophysiology and causative mechanism of the changes in bladder function remain unclear. The present study aimed to investigate the existence of ketamine-induced cystitis in a rat model and characterize the underlining mechanisms. Rats were assigned to blank control, normal saline (NS), low-dose ketamine (LK, 5 mg/kg), and high-dose ketamine (HK, 50 mg/kg) groups. The two experimental groups received ketamine hydrochloride daily for 16 weeks. All rats were housed individually for assessment of urinary frequency and urine volume. Urinary biomarkers were measured at different time points. Rat bladders were excised for histopathology, immunohistochemistry, and western blot analysis. Ketamine-treated rats had increased urinary frequency compared to NS-treated rats at Week 16. Urinary nitric oxide and antiproliferative factor levels were increased in ketamine-treated rats within the first 30 h after administration. After long-term ketamine administration, urinary glycoprotein GP51 and potassium levels were decreased in the HK and LK groups compared to the NS group. Ketamine-treated rats showed thickened bladder epithelial layer, increased expression of inducible nitric oxide synthase and occludin, and decreased expression of zonula occludens-1 in the bladder wall. Ketamine, or its urinary metabolites, disrupted the proliferation of bladder epithelial cells, resulting in defected bladder epithelial barrier. Subsequent leakage of urinary potassium causes a stress response in the bladder and provokes cystitis.
Similar content being viewed by others
References
Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW et al (2007) ‘Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13:311–313
Persson J (2010) Wherefore ketamine? Curr Opin Anaesthesiol 23:455–460
Lai Y, Wu S, Ni L, Chen Z, Li X, Yang S et al (2012) Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity. Urol Int 89:93–96
Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S et al (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102:1616–1622
Yeung LY, Rudd JA, Lam WP, Mak YT, Yew DT (2009) Mice are prone to kidney pathology after prolonged ketamine addiction. Toxicol Lett 191:275–278
Tan S, Chan WM, Wai MS, Hui LK, Hui VW, James AE et al (2011) Ketamine effects on the urogenital system—changes in the urinary bladder and sperm motility. Microsc Res Tech 74:1192–1198
Wood D, Cottrell A, Baker SC, Southgate J, Harris M, Fulford S et al (2011) Recreational ketamine: from pleasure to pain. BJU Int 107:1881–1884
Ratliff TL, Klutke CG, McDougall EM (1994) The etiology of interstitial cystitis. Urol Clin North Am 21:21–30
Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142
Matter K, Balda MS (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4:225–236
Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ (2004) Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 171:1554–1558
Zhang CO, Wang JY, Koch KR, Keay S (2005) Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 174:2382–2387
Keay SK, Zhang CO, Shoenfelt J, Erickson DR, Whitmore K, Warren JW et al (2001) Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57:9–14
Erickson DR (2001) Urine markers of interstitial cystitis. Urology 57:15–21
Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69:34–40
Parsons CL (2011) The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int 107:370–375
Xu DZ, Lu Q, Deitch EA (2002) Nitric oxide directly impairs intestinal barrier function. Shock 17:139–145
Parsons CL, Greene RA, Chung M, Stanford EJ, Singh G (2005) Abnormal urinary potassium metabolism in patients with interstitial cystitis. J Urol 173:1182–1185
Shupp Byrne DE, Sedor JF, Soroush M, McCue PA, Mulholland SG (2001) Interaction of bladder glycoprotein GP51 with uropathogenic bacteria. J Urol 165:1342–1346
Nomiya A, Nishimatsu H, Homma Y (2011) Interstitial cystitis symptoms associated with ketamine abuse: the first Japanese case. Int J Urol 18:735
Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, Rovner ES et al (2008) Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 179:1850–1856
Lundberg JO, Ehren I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg E et al (1996) Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 48:700–702
Birder LA, Wolf-Johnston A, Buffington CA, Roppolo JR, de Groat WC, Kanai AJ (2005) Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. J Urol 173:625–629
Keay S, Zhang CO, Trifillis AL, Hise MK, Hebel JR, Jacobs SC et al (1996) Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156:2073–2078
Keay S (2008) Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 20:2174–2179
Keay S, Leitzell S, Ochrzcin A, Clements G, Zhan M, Johnson D (2012) A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study. BMC Urol 12:17
Zacharias DA, Mullen M, Planey SL (2012) Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding. Int J Cell Biol 2012:150918
Shahjee HM, Koch KR, Guo L, Zhang CO, Keay SK (2010) Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res 29:160
Adamowicz P, Kala M (2005) Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 29:376–382
Liu L, Wei ZW, Jia J, Wang YJ (2010) Toxicokinetics of ketamine in rabbits. Fa Yi Xue Za Zhi 26:357–360
Byrne DS, Sedor JF, Estojak J, Fitzpatrick KJ, Chiura AN, Mulholland SG (1999) The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol 161:1786–1790
Parsons CL, Bautista SL, Stein PC, Zupkas P (2000) Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 164:1381–1384
Parsons CL, Hurst RE (1990) Decreased urinary uronic acid levels in individuals with interstitial cystitis. J Urol 143:690–693
Acknowledgments
The authors thank Dr. Paul Fraser for revising the manuscript. This work was supported by the National Nature Science Foundation of China (Grant No. 81100540), the Guangdong Natural Science Foundation (Grant No. S2012010008919 and S2013010014890).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gu, D., Huang, J., Yin, Y. et al. Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. Mol Biol Rep 41, 7313–7322 (2014). https://doi.org/10.1007/s11033-014-3616-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3616-5